Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-13

Clinical Trial Update: Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer

View source ↗

Summary

A clinical trial update reports changes in breast density and blood hormone levels in postmenopausal women with breast cancer treated with the aromatase inhibit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIMIDEX (anastrozole)
  • Aromasin (exemestane)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer | Status: COMPLETED